+103.5%
APLD vs GSK
+26.4%
+77.1%
-53.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.4% | -2.7% | +10.1% | +6.9% |
| 7D | +16.6% | -4.2% | +20.7% | +15.7% |
| 30D | -3.1% | -7.5% | +4.4% | -4.1% |
| 3M | -30.9% | -3.3% | -27.6% | -31.4% |
| 6M | +12.6% | -9.3% | +21.9% | +12.5% |
| YTD | +15.5% | +1.6% | +13.9% | +18.6% |
| 1Y | +103.5% | +25.5% | +78.0% | +97.1% |
| All | +103.5% | +26.4% | +77.1% | +97.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling